Abstract
Increased concentrations of serum ferritin are common in patients with malignant disease and appear to be a non-specific response. The present evidence does not suggest that serum ferritin assay is useful either for specific diagnosis or monitoring of malignant disease. A special role for acidic isoferritins in malignancy remains to be substantiated.
Similar content being viewed by others
References
Harrison P M, Clegg A A, May K: Ferritin structure and function, in Jacobs A, Worwood M (eds).Iron in Biochemistry and medicine, vol. II, pp. 131–171. London, Academic Press (1980).
Bomford A B, Munro H N: Biosynthesis of ferritin and isoferritins, in Jacobs A, Worwood M (eds).Iron in Biochemistry and Medicine, vol. II, pp. 173–202. London, Academic Press (1980).
Worwood M: Ferritin in human tissues and serum.Clin Haemat 11, 275 (1982).
Arosio P, Adelman T G, Drysdale J W: On ferritin heterogeneity. Further evidence for heteropolymens.J biol Chem 253, 4471 (1978).
Reissmann K R, Dietrich M R: On the presence of ferritin in the peripheral blood of patients with hepatocellular disease.J clin Invest 35, 588 (1956).
Wohlers S, Schonlau F: Uber das Vorkommen von Ferritin in Serum.Klin Woch 37, 445 (1959).
Aungst C W: Ferritin in body fluids.J Lab Clin Med 71, 517 (1968).
Addison G M, Beamish M R, Hales C N, Hodgkins M, Jacobs A, Llewellin P: An immunoradiometric assay for ferritin in the serum of normal subjects and patients with iron deficiency and iron overload.J Clin Path 25, 326 (1972).
Walters G O, Miller S M, Worwood M: Serum ferritin in concentration and iron stores in normal subjects.J Clin Path 26, 770 (1973).
Jacobs A, Worwood M: Ferritin in serum. Clinical and biochemical applications.New Engl J Med 292, 951 (1975).
Worwood M: Serum ferritin, inCRC Critical Reviews in Clinical Laboratory Sciences, pp. 171–204.
Worwood M: Serum ferritin, in Cook J D (ed):Methods in Haematology, vol. 1, pp. 59–89. London, Churchill-Livingstone.
Bieber C P, Bieber M M: Detection of ferritin as a circulating tumour-associated antigen in Hodgkin's disease.Nat Cancer Inst Monogr 36 147 (1973).
Sarcione D J, Stutzman L, Mittelman A: Ferritin synthesis by splenic tumour tissue of Hodgkin's disease.Experientia 31, 1334 (1975).
Sarcione E J, Smalley J R, Lema M J, Stutzman L: Increased ferritin synthesis and release by Hodgkin's disease peripheral blood lymphocytes.Int J Cancer 20, 339 (1977).
Worwood M, Summers M, Miller S, Jacobs A, Whittaker J A: Ferritin in blood cells from normal subjects and patients with leukaemia.Brit J Haemat 28, 27 (1974).
White G P, Worwood M, Parry D H, Jacobs A: Ferritin synthesis in normal and leukaemic lymphocytes.Nature 240, 584 (1974).
Cragg S J, Jacobs A, Parry D H, Wagstaff M, Worwood M: Isoferritins in acute leukaemia.Brit J Cancer 35, 635 (1977).
Wagstaff M, Worwood M, Jacobs A: Biochemical and immunological characterisation of ferritin from leukaemic cells.Brit J Haemat 45, 263 (1980).
Alpert E, Coston R L, Drysdale J W: Carcinofoetal human liver ferritins.Nature 242, 194 (1980).
Massover W H: Mouse hepatoma and liver ferritins. Comparative structural studies.Biochim biophys Acta 579, 169 (1979).
Marcus D M, Zinberg N: Isolation of ferritin from human mammary and pancreatic carcinomas by means of antibody immunoabsorbence.Arch Biochem Biophys 162, 493 (1974).
Alpert E, Quaroni A, Goldenberg D M Alterations in triptic peptide atoms of ferritins purified from human colon carcinoma.Biochim biophys Acta 581, 193 (1979).
Hann H-W L, Levey H M, Evans A E: Serum ferritin as a guide to therapy in neuroblastoma.Cancer Res 40, 1411 (1980).
Halliday J W, McKeering L V, Powell L W: Isoferritin composition of tissues and serum in human cancers.Cancer Res 36, 4486 (1976).
Miles L E M, Lipschitz D A, Bieber C P, Cook J D: Measurement of serum ferritin by a 2-site immunoradiometric assay.Analyt Biochem 61, 209 (1974).
Hazard J T, Drysdale J W: Ferritinaemia in cancer.Nature 265, 755 (1977).
Jones B M, Worwood M: An immunoradiometric assay for the acidic ferritin of human heart: application to human tissues, cells and serum.Clin Chim Acta 85, 81 (1978).
Jones B M, Worwood M, Jacobs A: Serum ferritin in patients with cancer: determination with antibodies to HeLa cells and spleen ferritin.Clin Chim Acta 166, 203 (1980).
Niitsu Y, Goto Y, Kohgo Y, Adachi C, Onodera Y, Urushizaki I: Evaluation of heart isoferritin assay for diagnosis of cancer, in Albertini A (ed.):Radioimmunoassay of Hormones Proteins and Enzymes, pp. 256–266. Amsterdam, Excerpta Medica.
Mori W, Asakawa H, Taguchi T, Sakai R: Human isoferritin and malignant neoplasms.Acta Haemat Jap 41, 1309 (1978).
Mack U, Cooksley W G E, Ferris R A, Powell L W, Halliday J W: Regulation of plasma ferritin in isolated perfused rat liver.Brit J Haemat 47, 403 (1981).
Prieto J, Barry M, Sherlock S: Serum ferritin in patients with iron overload and acute and chronic liver diseases.Gastroenterology 68, 525 (1975).
Konijn A M, Hershko C: Ferritin synthesis in inflammation. 1. Pathogenesis of impaired iron release.Brit J Haemat 37, 7 (1977).
Gregg P J, Eastham E J, Bell J I, Walder D N: Serum ferritin and dysbaric osteonecrosis.Undersea Biomed Res 4, 75 (1977).
Worwood M, Cragg S J, Wagstaff M, Jacobs A: Binding of human serum ferritin to concanavalinA. Clin Sci 56, 83 (1979).
Worwood M, Cragg S J, Williams A M, Wagstaff M, Jacobs A: The clearance of131 I-human plasma ferritin in man.Blood 60, 827 (1982).
Cragg S J, Covell A M, Burch A, Owen G M, Jacobs A, Worwood M: Turnover of131 I-human spleen ferritin in plasma.Brit J Haemat (in press).
Mack U, Powell L W, Halliday J W: A receptor for ferritin on hepatocytes.J biol Chem 258, 4672 (1983).
Covell A M: Turnover of ferritin in plasma. PhD thesis. University of Wales (1983).
Jones P A E, Miller S M, Worwood M, Jacobs A: Ferritinaemia in leukaemia and Hodgkin's disease.Brit J Cancer 27, 212 (1973).
Parry D H, Worwood M, Jacobs A: Serum ferritin in acute leukaemia at presentation and during remissions.Brit Med J 1, 245 (1975).
Matzner Y, Konijn A M, Hershko C: Serum ferritin in haematological malignancies.Am J Hemat 9, 13 (1980).
Siimes M A, Wang W C, Dalman P R: Elevated serum ferritin in children with malignancies.Scand J Haemat 19, 153 (1977).
Parry D H, Ricketts, Jacobs A: Serum ferritin during unmaintained remission in acute lymphoblastic leukaemia.Brit Med J 2, 1341 (1978).
Koller M-E, Romslo P H, Finne P H, Hanneberg B: Serial determinations of serum ferritin in children with acute lymphoblastic leukaemia.Acta Paediat Scand 68, 93 (1979).
Lang J M, Aber M, Methlin G, Oberling F: Serum ferritin during the course of chronic myeloid leukaemia. Increase of serum ferritin as a marker of dyserythropoiesis.Acta Haemat 67, 145 (1982).
May A, De Souza P, Barnes K, Kaaba S, Jacobs A: Erythroblast iron metabolism in sideroblastic marrows.Brit J Haem 52, 611 (1982).
Jacobs A, Slater A, Whittaker J A, Cannelos G, Wiernik P H: Serum ferritin concentration in untreated hodgkin's disease.Brit J Cancer 34, 162 (1976).
Marcus D M, Zinberg N: Measurement of serum ferritin by radioimmunoassay: results in normal individuals and patients with breast cancer.J Nat Cancer Inst 55, 791 (1975).
Jacobs A, Jones B, Ricketts C, Bulbrook R D, Wang D Y: Serum ferritin concentration in early breast cancer.Brit J Cancer 34, 286 (1976).
Coombes R C, Powles T J, Gazet J C, Ford H G, Slone J P, Laurence D J R, Neville A M: Biochemical markers in human breast cancer.Lancet 1, 132 (1977).
Coombes R C, Powles T J, Gazet J C, Ford H T, McKinna A, Gehrke C W, Keyser J W, Mitchell P E G, Patel S, Stimson, W H, Worwood M, Jones M, Neville A M: Screening for metastases in breast cancer: an assessment of biological and physical methods.Cancer 48, 310 (1981).
Bezwoda W, Derman D, Bothwell T, MacPhail P, Levin J, DeMoor N: Significance of serum concentrations of carcino embryonic antigen, ferritin and calcitonen in breast cancer.Cancer 48, 1623 (1981).
Nitti D, Fabris C, Del Favero G, Farini R, Crassi F, Farini A, Baccaglini U, Pedrazzoli S, Piccoli A, Lise M, Naccarato R: Serum ferritin in pancreatic disease. An accurate test of malignancy?.Digestion 25, 258 (1982).
Ito H, Takagi Y, Ando Y, Kubo A, Hashimoto S, Tsutsui F, Kurihara S: Serum ferritin levels in patients with cervical cancer.Obst Gyn 55, 358 (1980).
Grail A, Bates G, Milford Ward A, Jones W G, Hancock B W: Serum ferritin as a third marker in germ cell tumours.Eur J Cancer Clin Oncol 18, 261 (1982).
Hann H-W L, Evans A E, Cowin I J, Leitmeyer J E: Biological differences between neuroblastoma stages IV-S and IV: measurement of serum ferritin and E rosette inhibition in 30 children.New Engl J Med 305, 425 (1981).
Kew M C, Torrance J D, Derman D, Simon M, Macnab G M, Charlton R W, Bothwell T H: Serum and tumour ferritins in primary liver cancer.Gut 19, 294 (1978).
Chapman R W, Bassendine M S, Laulicht M, Gorman A, Thomas H C, Sherlock S, Hoffbrand A V: Serum ferritin and binding of serum ferritin to concanavalin A as a tumour marker in patients with primary liver cell cancer and chronic liver disease.Digest Dis Sci 27, 111 (1982).
Melia, W M, Bullock S, Johnson P J, Williams R: Serum ferritin in hepatocellular carcinoma: a comparison with alpha foetoprotein.Cancer 51, 2112 (1982).
Arosio P, Iacobello C, Montesoro E, Albertini A: Serum ferritin evaluation with radioimmunoassays specific for HeLa and liver ferritin types.Immun Lett 3, 309 (1981).
Cazzola M, Arosio P, Gobbi P G, Barosi G, Bergamaschi G, Dezza L, Iacobello C, Ascari E: Basic and acidic isoferritins in the serum of patients with Hodgkin's disease.Eur J Cancer Clin Oncol 19, 339 (1983).
International Committee for Standardisation in Haematology. Preparation, characterisation and storage of human ferritin for use as a standard for the assay of serum ferritin (in preparation).
Oertel J: An ion-exchange chromatography of serum ferritin in patients with malignant diseases.Tumour Diagnost 2, 99 (1981).
Worwood M, Covell A M, Cragg S J, Jacobs A: Turnover of ferritin in plasma.Proc Sixth Int Conf Proteins of Iron Storage and Transport Sapporo (1983).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jacobs, A. Serum ferritin and malignant tumours. Med. Oncol. & Tumor Pharmacother. 1, 149–156 (1984). https://doi.org/10.1007/BF02934136
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02934136